Age-related differences in 1p and 19q deletions in oligodendrogliomas

BMC Clinical Pathology

Roy H Rhodes¹  Marc R Del Bigio¹  Yvonne Myal¹ 

[1] Department of Pathology, University of Manitoba, 770 Bannatyne Ave., Winnipeg, Manitoba, Canada R3E 0W3

关键词: 19q;    chromosomes 1p;    gliomas;    PCR;    loss of heterozygosity;    Microsatellite markers;   

Others  :  1086466
DOI  :  10.1186/1472-6890-3-6

 received in 2003-06-19, accepted in 2003-12-11,  发布年份 2003

【 摘 要 】

Background

Recent reports indicate that anaplastic oligodendrogliomas frequently show allelic losses on chromosome arms 1p and 19q, and that these deletions are associated with better chemotherapeutic response and overall patient survival. Because of the diversified genetic makeup of the population and the centralized provincial referral system for brain tumor patients in Manitoba, the epidemiological features of such tumors sometimes differ from the published data acquired from non-community based settings. In this study, we assessed the prevalence of allelic deletions for chromosome arms 1p and 19q in anaplastic and in low-grade oligodendrogliomas in the Manitoba population.

Methods

Loss of heterozygosity (LOH) analysis of brain tumors was carried out using 4 microsatellite markers (D1S508, D1S2734, D19S219 and D19S412) and a PCR based assay. The tumors were consecutively acquired during the period September 1999–March 2001 and a total of 63 tumors were assessed.

Results

We found that allelic loss of chromosome 1p and 19q was higher in oligodendrogliomas than in other diffuse gliomas and that for anaplastic oligodendrogliomas, younger patients exhibited significantly more deletions than older patients (>60 years of age).

Conclusions

These studies suggest that age may be a factor in the genetic alterations of oligodendrogliomas. In addition, these studies demonstrate that this assay can easily be carried out in a cost-effective manner in a small tertiary center.

【 授权许可】

   
2003 Myal et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Kleihues P, Cavenee WK: Pathology and Genetics of Tumors of the Nervous System. World Health Organization classification of tumors. Lyon, France: IARC Press 2000.
• [2]von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Muller DJ, Przkora R, Waha A, Blumcke B, Wellenreuther R, Meyer-Puttlitz B, Schmidt O, Mollenhauer J, Poustka A, Stangl AP, Lenartz D, von Ammon K: Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000, 59:544-558.
• [3]Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988, 23:360-364.
• [4]Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990, 27:573-574.
• [5]Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479.
• [6]Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000, 18:636-645.
• [7]Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A: Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995, 54:91-5.
• [8]Sutherland GR, Florell R, Louw D, Choi NW, Sima AA: Epidemiology of primary intracranial neoplasms in Manitoba, Canada. Can J Neurol Sci 1987, 14:586-592.
• [9]Kleihues P, Louis DN, Scheithauer BW, orke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61:215-25.
• [10]Smith SA, Easton DF, Evans DG, Ponder BA: Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992, 2:128-131.
• [11]Louis DN, Holland EC, Cairn JG: Gliomas classification: a molecular reappraisal. Am J Pathol 2001, 159:779-786.
• [12]Burger PC, Scheithauer BW, Vogel FS: Surgical Pathology of the Nervous System and Its Coverings. New York: Churchill Livingstone 2002.
• [13]Sasaki H, Zlatescu MC, Betensky RA, Johnk LB, Cutone AN, Cairncross JG, Louis DN: Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". J Neuropathol Exp Neurol 2002, 61:58-63.
• [14]Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K: Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 2001, 158:1253-1262.
• [15]Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, von Deimling A: Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 2002, 61:321-8.
• [16]Nakamura M, Yang F, Fuijisawa H, Yonekawa Y, Kleihues P, Ohgaki H: Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropath Exp Neurol 2000, 59:539-543.
• [17]Rosenberg JE, Lisle DK, Burwick JA, Ueki K, von Deimling A, Mohrenweiser HW: Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 1996, 13:2483-2485.
• [18]Balani JP, Margraf L, Perry A, Vono MB, Cai DX, Rushing EJ, Watson ML, Bowers DC, White CL III, Raghavan R: Pediatric oligodendrogliomas: molecular characteristics. Mod Pathol 2002, 15:299A [Abstract].